Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway.

[1]  Jen-kun Lin,et al.  Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  K. Eguchi,et al.  Prospective Evaluation of the Feasibility of Cisplatin‐based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ Functions , 1995, Japanese journal of cancer research : Gann.

[3]  Dean P. Jones,et al.  Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.

[4]  Jen-kun Lin,et al.  Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. , 1996, Nutrition and cancer.

[5]  R. Kumar,et al.  Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. , 1995, Carcinogenesis.

[6]  P. Galle,et al.  Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. , 1997, The Journal of clinical investigation.

[7]  I. Fentiman,et al.  Cancer in the elderly: why so badly treated? , 1990, The Lancet.

[8]  John C Reed,et al.  Bcl-2 family proteins , 1998, Oncogene.

[9]  B. Aggarwal,et al.  Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. , 2002, Carcinogenesis.

[10]  T. Tan,et al.  Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin , 1998, Oncogene.

[11]  B. Aggarwal,et al.  Anticancer potential of curcumin: preclinical and clinical studies. , 2003, Anticancer research.

[12]  R. Orlowski,et al.  Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. , 2002, Cancer research.

[13]  C. Lequaglie,et al.  Bcl-2 protein and prognosis in patients with potentially curable non-small-cell lung cancer , 1998, Virchows Archiv.

[14]  A. Conney,et al.  Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. , 1992, Carcinogenesis.

[15]  R. Smart,et al.  Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. , 1988, Cancer research.

[16]  P. Bunn.  Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why? , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  B. Aggarwal,et al.  Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.

[18]  R. Yancik,et al.  Cancer in the elderly: meeting the challenge of an aging population. , 1993, Journal of the National Cancer Institute.

[19]  B. Aggarwal.  Apoptosis and nuclear factor-κb: a tale of association and dissociation , 2000 .

[20]  S. Sen,et al.  Combined evaluation of expression of telomerase, survivin, and anti‐apoptotic bcl‐2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers , 2004, Head & neck.

[21]  H. Ammon,et al.  Pharmacology of Curcuma longa , 1991, Planta medica.

[22]  N. Singh,et al.  Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53. , 2001, Biochemical and biophysical research communications.

[23]  M. Wieckowski,et al.  A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells. , 1999, Experimental cell research.

[24]  R. Dashwood,et al.  Caspase-8 and apoptosis-inducing factor mediate a cytochrome c-independent pathway of apoptosis in human colon cancer cells induced by the dietary phytochemical chlorophyllin. , 2003, Cancer research.

[25]  B. Dörken,et al.  Adenine deoxynucleotides fludarabine and cladribine induce apoptosis in a CD95/Fas receptor, FADD and caspase-8-independent manner by activation of the mitochondrial cell death pathway , 2004, Oncogene.

[26]  O. Brodin,et al.  Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials , 1995 .

[27]  L. Howells,et al.  Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex , 1999, Oncogene.

[28]  Gang Li,et al.  Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. , 2001, Experimental cell research.

[29]  J. Tillement,et al.  Curcumin induces the mitochondrial permeability transition pore mediated by membrane protein thiol oxidation , 2001, FEBS letters.

[30]  N. Altorki,et al.  Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. , 1999, Carcinogenesis.

[31]  Chunhua Han,et al.  Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9 , 2005, International journal of cancer.

[32]  H. Choy,et al.  p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma , 1996, Cancer.

[33]  Neeta Singh,et al.  Insights into the molecular mechanism of apoptosis induced by TNF-alpha in mouse epidermal JB6-derived RT-101 cells. , 2002, Biochemical and biophysical research communications.

[34]  K. Propert,et al.  A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. , 1990, The New England journal of medicine.

[35]  S. Dey,et al.  Host cyclooxygenase-2 modulates carcinoma growth. , 2000, The Journal of clinical investigation.